1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
High circulating activin A plasma levels are associated with tumour stage and poor survival in treatment-naive lung squamous cell cancer patients
(
- Contribution to journal › Article
- 2024
-
Mark
A registry-based study on universal screening for defective mismatch repair in colorectal cancer in Denmark highlights disparities in screening uptake and counselling referrals
(
- Contribution to journal › Article
- 2023
-
Mark
Natural flavonoids exhibit potent anticancer activity by targeting microRNAs in cancer : A signature step hinting towards clinical perfection
(
- Contribution to journal › Article
- 2022
-
Mark
The STAT3 inhibitor GPB730 enhances the sensitivity to enzalutamide in prostate cancer cells
(
- Contribution to journal › Article
-
Mark
Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer
(
- Contribution to journal › Article
- 2021
-
Mark
Improved survival in several cancers with use of H1-antihistamines desloratadine and loratadine
(
- Contribution to journal › Article
-
Mark
Anti-tumor effects of rigosertib in high-risk neuroblastoma
(
- Contribution to journal › Article
- 2015
-
Mark
Sex Steroid Hormone Receptor Expression Affects Ovarian Cancer Survival.
(
- Contribution to journal › Article
- 2013
-
Mark
snoRNPs Regulate Telomerase Activity in Neuroblastoma and Are Associated with Poor Prognosis.
(
- Contribution to journal › Article
-
Mark
Impact of perfusion map analysis on early survival prediction accuracy in glioma patients.
(
- Contribution to journal › Article